Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0311-06

EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a...

Agilent Technologies, Inc. / initiated 2005-10-14 / Terminated

Dakocytomation California Inc began a recall of EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and as a... on . The reason FDA records is "This recall has been initiated due to a formulation error in the EnVision+ visualization reagent". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0311-06
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Agilent Technologies, Inc.
Product
EnVision+, an ImmunoHistoChemistry reagent. This in-vitro diagnostic (reagent) is marketed both as a component in various finished assay kits and as a standalone product. Model Number K4001
Product code
NJT Immunohistochemistry Reagents And Kits
Reason for recall
This recall has been initiated due to a formulation error in the EnVision+ visualization reagent.
FDA root cause
Other
Action
Notification letter dated October 14, 2005 was sent by certified mail to cosignees instructing dosposal of product.
Quantity in commerce
Lots 045036=632, 065022=805 &, 085032=274
Distribution
Nationwide to: AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MN, NC, NE, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, and WV. Worldwide to: Argentina, Bermuda, Brazil, Canada, Costa Rica, Denmark, Japan, Mexico, New Zealand, and Uruguay.
Product codes and lots
K4001: Lots 045036, 065022, 085032